Expression of concern: "Chemerin suppresses neuroinflammation and improves neurological recovery via CaMKK2/AMPK/Nrf2 pathway after germinal matrix hemorrhage in neonatal rats" [BRAIN BEHAV IMMUN, Volume 70 (2018) 179-193].

IF 7.6 2区医学 Q1 IMMUNOLOGY

Brain, Behavior, and Immunity Pub Date : 2025-10-01 Epub Date: 2025-05-20 DOI:10.1016/j.bbi.2025.05.017

Yixin Zhang, Ningbo Xu, Yan Ding, Yiting Zhang, Qian Li, Jerry Flores, Mina Haghighiabyaneh, Desislava Doycheva, Jiping Tang, John H Zhang

引用次数: 0

查看原文本刊更多论文

关注表达：“新生大鼠生发基质出血后，Chemerin通过CaMKK2/AMPK/Nrf2途径抑制神经炎症并改善神经恢复”[BRAIN behavior immune, vol . 70(2018) 179-193]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Brain, Behavior, and Immunity 医学-免疫学

CiteScore

29.60

自引率

2.00%

发文量

290

审稿时长

28 days

期刊介绍： Established in 1987, Brain, Behavior, and Immunity proudly serves as the official journal of the Psychoneuroimmunology Research Society (PNIRS). This pioneering journal is dedicated to publishing peer-reviewed basic, experimental, and clinical studies that explore the intricate interactions among behavioral, neural, endocrine, and immune systems in both humans and animals. As an international and interdisciplinary platform, Brain, Behavior, and Immunity focuses on original research spanning neuroscience, immunology, integrative physiology, behavioral biology, psychiatry, psychology, and clinical medicine. The journal is inclusive of research conducted at various levels, including molecular, cellular, social, and whole organism perspectives. With a commitment to efficiency, the journal facilitates online submission and review, ensuring timely publication of experimental results. Manuscripts typically undergo peer review and are returned to authors within 30 days of submission. It's worth noting that Brain, Behavior, and Immunity, published eight times a year, does not impose submission fees or page charges, fostering an open and accessible platform for scientific discourse.